. Author manuscript; available in PMC: 2018 Feb 1.

Published in final edited form as: Med Sci Sports Exerc. 2017 Feb;49(2):254–264. doi: 10.1249/MSS.0000000000001101

Table 1.

Body composition and metabolic characteristics

	HCR		LCR		2-way ANOVA statistics

	SED	EX	SED	EX
Perigonadal fat depot mass (g)	6.71 ± 1.22	9.72 ± 1.75	14.11 ± 1.33	8.61 ± 1.38	Line, P=0.042 Line × Treatment, P=0.008
Perirenal fat depot mass (g)	3.38 ± 0.33	5.95 ± 1.19	9.70 ± 0.80	4.18 ± 0.81	Line, P=0.015 Line × Treatment, P<0.001
Omental fat depot mass (g)	0.38 ± 0.04	0.79 ± 0.12	0.75 ± 0.12	0.48 ± 0.09	Line, P=0.002 Line × Treatment, P=0.003
BAT/WAT (g·g⁻¹)	0.030 ± 0.003	0.025 ± 0.004	0.015 ± 0.001	0.027 ± 0.006	NS
Liver (g)	6.67 ± 0.54	8.42 ± 0.53	6.71 ± 0.23	6.42 ± 0.14	Line, P=0.03 Line × Treatment, P=0.023
TG (mg·dl⁻¹)	32.71 ± 5.29	36.00 ± 6.33	52.00 ± 4.78	34.57 ± 1.90	Line × Treatment, P=0.037
NEFA (mmol·l⁻¹)	0.31 ± 0.05	0.42 ± 0.07	0.45 ± 0.05	0.27 ± 0.05	Line × Treatment, P=0.022
HDL (mg·dl⁻¹)	24.43 ± 1.34	29.00 ± 1.08	30.35 ± 1.31	29.85 ± 1.24	Line, P=0.026 Line × Treatment, P=0.046
LDL (mg·dl⁻¹)	2.28 ± 0.18	1.50 ± 0.18	3.21 ± 0.26	2.85 ± 0.24	Line, P<0.001 Treatment, P=0.029
Insulin (pg·ml⁻¹)	2.02 ± 0.49	2.95 ± 0.60	4.05 ± 0.76	2.87 ± 0.41	Line, P=0.067 (NS)
Glucose (mg·dl⁻¹)	153.8 ± 4.9	166.12 ± 5.6	160.1 ± 7.7	149.0 ± 2.8	Line × Treatment, P=0.041
HOMA-IR index	14.31 ± 4.07	22.40 ± 4.80	30.11 ± 6.13	19.18 ± 2.76	Line × Treatment, P=0.041
Adipocyte-IR index	0.714 ± 0.27	1.185 ± 0.41	1.820 ± 0.46	0.727 ± 0.16	Line × Treatment, P=0.037

Body composition and metabolic markers were analyzed. Two-way ANOVA for line (i.e., HCR vs. LCR), treatment (i.e., SED vs. EX) and line × treatment interaction effects were determined; values are means ± SE (n=7–8 per group). BAT= brown adipose tissue; WAT = white adipose tissue; TG= triglycerides; NEFA = non-esterified fatty acids; HDL= high-density lipoprotein; LDL=low-density lipoprotein; HOMA-IR = homeostasis model assessment of insulin resistance.